Story thread · 2 reports / 1 sources
Hagerty outlines 2026 adjusted EBITDA of $270M-$280M as written premium growth outlook rises to 16%-17%
seekingalpha.com · 5d
First report: Pediatrix reaffirms $280M-$300M 2026 adjusted EBITDA outlook while building telehybrid medicine platform — seekingalpha.com, 7d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.